The optimal reperfusion strategy for patients with ST-segment elevation myocardial infarction who are admitted to community hospitals without a catheterization laboratory is still a matter of debate. The long-term results of the DANAMI-2 study contribute to the evidence base for optimal reperfusion, but should be interpreted with caution and in the context of the wider literature on this subject.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Andersen, H. R. et al. for the DANAMI-2 Investigators. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N. Engl. J. Med. 349, 733–742 (2003).
Nielsen, P. H. et al. for the DANAMI-2 Investigators. Primary angioplasty versus fibrinolysis in acute myocardial infarction: long-term follow-up in the Danish Acute Myocardial Infarction 2 trial. Circulation 121, 1484–1491 (2010).
Keeley, E. C., Boura, J. A. & Grines, C. L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361, 13–20 (2003).
Van de Werf, F. et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur. Heart J. 29, 2909–2945 (2008).
Kushner, F. G. et al. 2009 Focused Updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 120, 2271–2306 (2009).
Bonnefoy, E. et al. Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up. Eur. Heart J. 30, 1598–1606 (2009).
Armstrong, P. W. et al. The STREAM (Strategic Reperfusion Early After Myocardial Infarction) study. Am. Heart J. (in press).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
F. Van de Werf has acted as a consultant and received speakers' bureau honoraria from Boehringer Ingelheim and Genentech. He has also received research support from Boehringer Ingelheim.
Rights and permissions
About this article
Cite this article
Van de Werf, F. Transport for PCI versus fibrinolysis—long-term data scrutinized. Nat Rev Cardiol 7, 419–420 (2010). https://doi.org/10.1038/nrcardio.2010.97
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2010.97
